Friday approved Vivus Inc.'s avanafil treatment for
erectile dysfunction, giving the small company, which has
struggled to bring a weight loss drug to market, a potentially
lucrative commercial product.
Saturday, April 28, 2012
FDA approves Vivus drug for erectile dysfunction
WASHINGTON, April 27 (Reuters) - U.S. health regulators on
Friday approved Vivus Inc.'s avanafil treatment for
erectile dysfunction, giving the small company, which has
struggled to bring a weight loss drug to market, a potentially
lucrative commercial product.
Friday approved Vivus Inc.'s avanafil treatment for
erectile dysfunction, giving the small company, which has
struggled to bring a weight loss drug to market, a potentially
lucrative commercial product.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment